DOSEF.US Doseology Sciences Inc.

Healthcare Biotechnology USA Stocks
0.0963 USD
Close of Nov 7, 2026
0.0516 1.00
Market cap
USD 779K
P/E
-
P/B
1.00x
ROE
-112.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Mar 2026.

Is DOSEF.US undervalued?

Graham number

The Graham number of Doseology Sciences Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Doseology Sciences Inc. fundamental analysis

No fundamental analysis for Doseology Sciences Inc. yet.

Doseology Sciences Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Doseology Sciences Inc.

Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., develops, manufactures, and sells nutritional wellness products in Canada. The company offers oral stimulants, medicinal mushroom products, tinctures, and brain-focused nutritional and wellness products. The company sells its products online and offline. Doseology Sciences Inc. was formerly known as Pcybin Therapeutic Inc. and changed its name to Doseology Sciences Inc. in January 2020. The company was incorpor…

Full company profile